Join
Live feed
·
PRReleasevia Quantisnow
Vaccitech plc logo

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer

ByQuantisnow·Wall Street's wire, on your screen.
VACC· Vaccitech plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VACC (Vaccitech plc) and more on Quantisnow.